ProQR National Institutes Of Health ClinicalTrials.gov Listing For Co.'s 'Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Advanced Vision Loss'